EMAIL THIS PAGE TO A FRIEND

Menopause international

Gonadotrophin receptor hormone analogues in combination with add-back therapy: an update.


PMID 22611225

Abstract

Gonadotrophin receptor hormone analogues (GnRHa) have been used in a range of sex hormone-dependent disorders. In the management of premenstrual syndrome, they can completely abolish symptoms. The success of GnRHa in the treatment of endometriosis and adjuvant therapy in the management of fibroids is proven. This efficacy does not come without a cost and the side-effects of the hypo-estrogenic state have limited their application. The use of add-back therapy to counter these effects has enabled wider application, longer durations of treatment and an increase in compliance. This review article is an update on the evidence supporting gonadotrophin receptor hormone analogues in combination with add-back therapy.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

Y0000668 Tibolone for system suitability, European Pharmacopoeia (EP) Reference Standard
C21H28O2